While in children and adolescents with proven GH deficiency (GHD), the benefits of GH as replacement therapy are clear, including improvement of hypertension, in older individuals, the potential adverse effects (primarily the risk of development of malignancy) limit its use and therefore, the role remains controversial. This evidence concerns the gene GH1 and hypertensive disorder.